Top Markets
#1 Black Phoenix Black Phoenix +742.82%
#2 Beam Beam +37.06%
#3 Bless Bless +18.81%
#4 THORChain THORChain +18.49%
#5 SAFEcoin SAFEcoin +17.39%
#6 TENDIES TENDIES +15.64%
#7 EfficientFrontier EfficientFrontier +15.43%
#8 MiL.k Alliance MiL.k Alliance +14.60%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +14.31%
#10 THORChain Yield THORChain Yield +13.92%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Pharvaris N.V. Pharvaris N.V.

Pharvaris N.V.

PHVS
Pozycja w akcjach #5575
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the... Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Cena akcji
$36.98
Ostatnia synchronizacja: 2026-08-26
Kapitalizacja rynkowa
$2.58B
Zmiana (1 dzień)
-0.67%
Zmiana (1 rok)
55.51%
Kraj
NL
Handel Pharvaris N.V. (PHVS)

Kategoria

Healthcare
Historia ceny akcji dla Pharvaris N.V. (PHVS)
Najwyższa cena zamknięcia: $35.74 dnia 2026-08-01

Najniższa cena zamknięcia: $31.41 dnia 2021-02-01
Historia cen akcji firmy Pharvaris N.V. od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 9.05%
2025 33.94%
2024 -24.64%
2023 230.41%
2022 -49.99%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.38 41.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.75%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.35 491.02%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $762.91 6.87%
CH